Cipla Ltd.
NSE: CIPLA · Healthcare
Sector
Healthcare
Size band
Large cap
Market cap
97,116cr
P/E
21
ROE
17.2%
Dividend yield
1.3%
No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.
Measured against
Peer set
Pharmaceuticals & Drugs · largest 12 of 82 measured at Q1 FY27 · financials via Screener| Company | Operating margin | Revenue growth |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 29.0% | 10.5% |
| Divi's Laboratories Ltd. | 41.0% | 27.8% |
| Torrent Pharmaceuticals Ltd. | 34.0% | 54.8% |
| Lupin Ltd. | 30.0% | 32.1% |
| Dr. Reddy's Laboratories Ltd. | 11.0% | −5.5% |
| Cipla Ltd. | 17.0% | 2.3% |
| Zydus Lifesciences Ltd. | 24.0% | 22.0% |
| Mankind Pharma Ltd. | 26.0% | 12.9% |
| Aurobindo Pharma Ltd. | 21.0% | 16.3% |
| Torrent Power Ltd. | 19.0% | 2.8% |
| Alkem Laboratories Ltd. | 20.0% | 10.9% |
| Glenmark Pharmaceuticals Ltd. | 20.0% | 23.1% |
No guidance on record.
This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Cipla Ltd..
On air
20 calls · outcomes not trackedRecorded as stated on air, with the analyst's SEBI registration status where it was given. Anchor calls carry no registration and are marked. Bharatstox does not make, endorse or repeat these calls, and none of them is our view.
| Channel & show | Aired | Stated target | Stated stop | Outcome |
|---|---|---|---|---|
| CNBC AwaazCNBC Awaax · no registration attached | 2 Sep | +1.9% | -1.6% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 2 Sep | +2.0% | -1.6% | still open |
| Zee BusinessZee Business · no registration attached | 1 Sep | +4.7% | -3.4% | still open |
| Zee BusinessZee Business · no registration attached | 1 Sep | +4.7% | — | still open |
| Zee BusinessZee Business · no registration attached | 1 Sep | +5.6% | -2.6% | still open |
| Zee BusinessZee Business · no registration attached | 31 Aug | +2.6% | -2.3% | still open |
| Zee BusinessZee Business · no registration attached | 26 Aug | +21.2% | — | still open |
| Zee BusinessZee Business · no registration attached | 6 Aug | +2.5% | -0.9% | still open |
| Zee BusinessZee Business · no registration attached | 6 Aug | +2.4% | — | still open |
| Zee BusinessZee Business · no registration attached | 6 Aug | +2.4% | -0.9% | still open |
| Zee BusinessZee Business · no registration attached | 6 Aug | +1.8% | -1.6% | still open |
| Zee BusinessZee Business · no registration attached | 6 Aug | +1.8% | -1.6% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 6 Aug | +6.6% | -4.6% | still open |
| Zee BusinessZee Business · no registration attached | 6 Aug | +2.2% | -1.2% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 6 Aug | +42.9% | -19.0% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 6 Aug | +19.0% | -19.0% | still open |
| Zee BusinessZee Business · no registration attached | 6 Aug | +3.4% | -1.3% | still open |
| Zee BusinessZee Business · no registration attached | 6 Aug | +2.2% | -1.2% | still open |
| Zee BusinessZee Business · no registration attached | 6 Aug | +2.1% | -1.3% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 6 Aug | +3.6% | -1.2% | still open |
Shareholding
change across 4 filings| Category | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Change |
|---|---|---|---|---|---|
| Promoters | 29.2 | 29.2 | 29.2 | 29.2 | 0.0 |
| Foreign institutions | 20.2 | 22.6 | 23.9 | 24.6 | −4.4 |
| Domestic institutions | 34.6 | 32.0 | 30.7 | 30.3 | +4.3 |
| Retail & others | 16.0 | 16.3 | 16.1 | 16.0 | 0.0 |
As filed with the exchange for the periods ending Sep 25 to Jun 26.
Filings
latest 25 of 392- Press Release3 Sept 2026
- General Updates3 Sept 2026
- Please find enclosed disclosure3 Sept 2026
- Copy of Newspaper Publication2 Sept 2026
- Please find attached newspaper publication regarding opening of special window for re-lodgement of transfer and dematerialisation of physical shares2 Sept 2026
- Press Release31 Aug 2026
- Please find enclosed press release titled "Cipla and SBP Group sign exclusive licensing agreement for potential best-in-class HER2 bispecific ADC Rolditamig Deuderuxtecan (TQB2102)"31 Aug 2026
- Please find enclosed disclosure.28 Aug 2026
- General Updates28 Aug 2026
- Other Restructuring27 Aug 2026
- Please find enclosed disclosure.27 Aug 2026
- Analysts/Institutional Investor Meet/Con. Call Updates27 Aug 2026
- Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / ....27 Aug 2026
- In terms of regulation 30 of SEBI (LODR) Regulations, 2015, we hereby notify that the Operations and Admisnistrative Committee of the Company on 26th August, 2026 has allotted 5,281 fully ....26 Aug 2026
- ESOP/ESOS/ESPS26 Aug 2026
- General Updates25 Aug 2026
- Please find enclosed disclosure25 Aug 2026
- Cipla has informed the exchange about receipt of order from Hon''ble NCLT, Mumbai Bench19 Aug 2026
- Amalgamation/Merger19 Aug 2026
- General Updates11 Aug 2026
- General Updates4 Aug 2026
- In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirments) Regulations, 2015, we hereby notify that the Operations and Administrative Committee ....31 Jul 2026
- Allotment of Securities31 Jul 2026
- Updates27 Jul 2026
- Please find enclosed disclosure27 Jul 2026
The 25 most recent of 392 filings we hold for CIPLA, back to January 2024. Every filing, by day.
Disclaimer
Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Broadcast calls are reproduced as stated on air, attributed, with the analyst's SEBI registration status where given; they are not our calls and not our view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.